43 results about "Lead blood" patented technology

A sensor for blood component analysis, which allows even a trace amount of blood to be led to an analysis portion reliably. The sensor for blood component analysis includes a substrate, a spacer, and a cover. The cover is disposed on the substrate with the spacer intervening between the cover and the substrate, whereby a space that serves as an analysis portion and a channel for leading blood to the analysis portion is formed inside the sensor. Through holes are formed in the substrate and the spacer, respectively, so that a common through hole through which a needle of a lancet can pass is formed when the spacer is disposed on the substrate. The through hole of the spacer communicates with the channel and a top of the through hole of the spacer is covered with the cover, whereby a lancing portion is formed by the common through hole and a portion of the cover covering the top of the through hole of the spacer. In use, the sensor is placed at a position where blood collection is to be performed, the portion of the cover covering the lancing portion is broken through with the needle of the lancet so that the needle is allowed to pass through the common through hole to puncture the position, and blood that has come out is guided by a downwardly protruding burr formed when the cover is broken through so that the blood is led to the channel and flows through the channel to be led to the analysis portion.

A pancreatic controller, comprising:at least one electrode adapted for electrifying at least a portion of a pancreas; anda controller programmed to electrify said electrode so as to positively control at least the effect of at least two members of a group consisting of blood glucose level, blood insulin level and blood level of another pancreatic hormone. In one example, the controller controls insulin, glucagon and / or glucose blood levels.

The invention relates to the field of human health influence factor detection instruments, in particular to a wrist watch device with an intelligent health monitoring and alarming system and a method thereof. The wrist watch device comprises a wrist watch shell and a watch strap. A circuit of the intelligent health monitoring and alarming system is arranged in the cavity of the wrist watch shell, a display screen and an environment temperature infrared sensor are arranged on the face of the shell, an LED blood flow velocity acceleration sensor, an infrared body temperature sensor and a humidity sensor are equidistantly arranged in the middle of the bottom of the shell, and connection watch strap lugs are arranged on the left side and the right side of the shell. Wire connection terminals are arranged on the connection watch strap lugs. Ceramic pressure sensors are adopted as pulse sensors, installed at the contact portion of the bottom of the watch strap and the wrist of the human body and equidistantly arranged on the bottom of the watch strap in the vertical direction. Keys are arranged on the upper side of the shell. The wrist watch device with the intelligent health monitoring and alarming system and the method thereof have the advantages that the sensors and a single-chip microcomputer control the circuit to monitor various health indexes of users in real time, results are displayed through the display screen, and information is fed back to the users.

The invention relates to a medical inner support hollow tubular sac catheter which comprises a catheter body, a tubular sac and a filling tube connected with the tubular sac, wherein the catheter body is sheathed with a sleeve; the medical inner support hollow tubular sac catheter is characterized in that the front end of the sleeve is provided with more than two sliding sections, wherein the circumference of the front end of the first sliding section is evenly articulated with N support rods; the sides of M support pieces are articulated with each other so as to form an inner wall which is in a circular ring shape after being stretched; and the sliding sections and the support rods form umbrella-shaped support for the circular-ring-shaped inner wall. The medical inner support hollow tubular sac catheter leads blood flow with the quantity being more than 50% of original blood flow filling capacity to pass through a support cavity, and ensures the blood flow at far and near ends of treatment parts not to be blocked in the treatment process, thus reducing the probability of vascular accident in the period of treatment and surrounding treatment, improving the safety of operation, andsolving the problem of blocking branch artery blood supply when in treatment in a branch blood vessel cavity.

The invention discloses a coated stent, comprising a stent section, a coat and a reinforcement; wherein, two ends of a metal wire are connected to form the reinforcement which is fixed on the coat. The invention is characterized in that: since the coated stent adopts the independent reinforcement, the reinforcement is separated from the stent section, avoiding the risk that in prior art the integral connection of the reinforcement and the front and end stent sections can lead to fracture; furthermore, the hindrance produced in the course of releasing and assembling the whole stent is reduced,which is helpful for the releasing and assembling of the coated stent. The invention also discloses another coated stent comprising a stent section and a coat; wherein, two ends of a metal wire are connected by laser welding to form the stent section. Since two ends of the metal wire in each stent section are not fixedly connected, prior coated stent can lead blood damage; therefore, the risk is avoided.

Systems, devices, and methods for monitoring an analyte in a subject. The systems, devices, and methods may include a sensor element being designed and configured for detecting said analyte in blood flowing through a bone of the subject, and a fixation element that is capable of fixating said sensor element within the bone tissue

The present invention provides antibodies that bind to the human glucagon receptor, designated GCGR and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GCGR. The antibodies of the invention are useful for lowering blood glucose levels and blood ketone levels and are also useful for the treatment of diseases and disorders associated with one or more GCGR biological activities, including the treatment of diabetes, diabetic ketoacidosis, long-term complications associated with diabetes, or other metabolic disorders characterized in part by elevated blood glucose levels, including stress hyperglycemia.

A sensor for blood component analysis, which allows even a trace amount of blood to be led to an analysis portion reliably. The sensor for blood component analysis includes a substrate, a spacer, and a cover. The cover is disposed on the substrate with the spacer intervening between the cover and the substrate, whereby a space that serves as an analysis portion and a channel for leading blood to the analysis portion is formed inside the sensor. Through holes are formed in the substrate and the spacer, respectively, so that a common through hole through which a needle of a lancet can pass is formed when the spacer is disposed on the substrate. The through hole of the spacer communicates with the channel and a top of the through hole of the spacer is covered with the cover, whereby a lancing portion is formed by the common through hole and a portion of the cover covering the top of the through hole of the spacer. In use, the sensor is placed at a position where blood collection is to be performed, the portion of the cover covering the lancing portion is broken through with the needle of the lancet so that the needle is allowed to pass through the common through hole to puncture the position, and blood that has come out is guided by a downwardly protruding burr formed when the cover is broken through so that the blood is led to the channel and flows through the channel to be led to the analysis portion.

The invention relates to medicinal gelatin microspheres and a preparation method thereof, and belongs to the field of medicine preparation. The active ingredient of the medicinal gelatin microspheres is trimetazidine or a medicinal salt of the trimetazidine. The preparation of the microspheres adopts a chemical cross-linking method, and comprises steps of emulsification, deoiling and dewatering, chemical cross-linking, washing and drying, and the like. According to the preparation method, the particle size, the appearance, the encapsulation efficiency, the drug loading rate are adopted as indexes to comprehensively optimize the carrier, the oil phase, the dewatering and deoiling agent, the cross-linking curing agent, and other reagents added in the process, wherein the carrier, the oil phase, the dewatering and deoiling agent, the cross-linking curing agent, and other reagents are suitable for preparation of the microspheres of the present invention. The prepared microspheres have characteristics of smooth surface, particle size of 50-200 mum, drug loading rate of 30-35%, and has a slow release effect under the common dissolution conditions. In addition, the blood drug level of the microspheres is stable in vivo, and is better than the blood drug level of ordinary tablets.

The invention applies for providing lipase capable of reducing cholesterol and blood fat levels in bodies of animals and use thereof. Researches on the influences of the addition of the lipase in daily rations on the growth property, apparent metabolizable energy, blood biochemical indexes and abdominal fat rate of commercial broiler chicken are performed. The results of the researches indicate that the addition of the lipase can improve the growth property and apparent metabolizable energy of boiler chicken and reduce the content of triglyceride, low-density lipoprotein and high-density lipoprotein in blood and abdominal fat rate and that the improvement on the e growth property and apparent metabolizable energy and the reduction in the triglyceride, low-density lipoprotein, high-density lipoprotein and abdominal fat rate reach the greatest extend in the middle term of a test.

The invention provides a blood lead content reducing medicine for treating plumbism, wherein the medicine is prepared from Chinese medicinal herbs including, mother-of-pearl, deer horn frost, and oldenlandia, eucommia bark, lysimachia christinae, coix seed, and poria cocos wolf.

The invention provides a blood lipid level and coronary heart disease related rs7901016 detecting system and related application, particularly determines relevance between single nucleotide polymorphism rs7901016 and blood lipid level, provides application of reagent materials and / or instruments for detecting polymorphism of a rs7901016 locus in a sample of a to-be-tested individual to preparationof a detecting system for assessment of blood lipid level, dyslipidemia and / or coronary heart disease risks, and further provides the detecting system for assessment of the blood lipid level, dyslipidemia and / or coronary heart disease risks. The detecting system comprises the reagent materials and / or instruments for detecting polymorphism of the rs7901016 locus in the sample of the to-be-tested individual, wherein rs7901016 is remarkably related to LDL-C level, and rs7901016 locus T allele carriers are higher in LDL-C level and / or coronary heart disease risks than non-carriers.

The invention relates to an internal drug assay determination method in the field of medical examination, which relates to a method for measuring human plasma imidazole density. It dose equal indicative elution on acid traveling phase condition after doing first treatment to the tested sample by protein depositing and uses ultraviolet detector to test it after chromatographic column separating.

A use of a Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels is disclosed. Lactobacillus reuteri GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factor and lipid synthesis and promotes gene expression related to cholesterol metabolism. Lactobacillus reuteri GMNL-263 is utilized to produce a composition for decreasing blood lipid levels, thereby achieving the aim of hyperlipidemia treatment.

The invention relates to a production method of an egg containing rich selenium, which can be used for reducing blood lead level of children. The method of the invention comprises the steps as follows: (1) the material containing rich selenium is added into chicken feed with a ratio of 0.1 percent to 15 percent and is stirred and mixed evenly, thus obtaining special chicken feed for reserving; (2) feeding chicken with the special chicken feed for 3-5 days according to normal feeding amount and then adding 0.001-0.01 portions of selenium element into the chicken feed for feeding in the sixth-tenth days; (3) adding 0.001-0.005 portions of selenium element into the chicken feed for feeding layer chickens in the 10th-15th days and collecting eggs for testing and controlling the content of selenium element in 2.0-2.5PPM. Besides containing rich selenium, the eggs produced according to the method of the invention contain higher beneficial elements of calcium and zinc and less harmful elements of lead and mercury. By clinically observing to more than 200 children of 3-6 years old, the produced egg in the method of the invention can effectively reduce blood lead level of children.

The invention provides a blood lipid level related single nucleotide polymorphism rs4883263 detecting system and related application, particularly determines relevance between single nucleotide polymorphism rs4883263 and blood lipid level, provides application of reagent materials and / or instruments for detecting polymorphism of a rs4883263 locus in a sample of a to-be-tested individual to preparation of a detecting system for assessment of blood lipid level and / or dyslipidemia risks, and further provides the detecting system for assessment of the blood lipid level and / or the dyslipidemia risks. The detecting system comprises the reagent materials and / or instruments for detecting polymorphism of the rs4883263 locus in the sample of the to-be-tested individual, wherein rs4883263 is remarkably related to HDL-C level, and rs4883263 locus C allele carriers are lower in HDL-C level and higher in dyslipidemia risks than non-carriers.

The invention provides lipase capable of effectively reducing the cholesterol level and blood fat level of a human body and an application of the lipase in preparing anti-hypercholesterolemia and anti-hyperlipemia medicament. High-fat emulsion is injected into the stomach of a rat to obtain a non-alcoholic simple fatty liver model of the rat, and the preventive treatment effect of the lipase on the rat is checked. The result shows that compared with the model control group, the lipase dose group can effectively reduce the activity of ALT and triglyceride content of hepatic tissue, and can reduce the level of fatty degeneration of liver simultaneously, thereby having the value of popularizing and application.

The invention provides an edible composition having the efficacy of assisting in improving blood fat level and an application of the edible composition, in particular an edible composition containinglinseed oil. The edible composition consists of the following raw materials of linseed oil, isomerized lactose and soybean peptide powder, wherein the mass ratio of the linseed oil to the isomerized lactose to the soybean peptide powder is 1 to (0.16-1.0) to (0.03-0.05). The composition can be added to liquid dairy products, and the liquid dairy products having favorable stability and favorable mouth feel within long shelf life can be made; and the composition and the liquid dairy products can improve the blood fat level to a certain extent after being eaten, can assist in reducing blood fat and is beneficial for human health.

The invention relates to health food used for assisting reducing blood fat and a preparation method thereof. The health food mainly comprises the following material components: agar, sodium alginate, hawthorns, gynostemma pentaphyllum, rhizoma alismatis and semen cassia. By limiting components and proportion of the health food and a preparation method of each traditional Chinese medicine extract, absorption of cholesterol can be restrained, excretion of cholesterol and triglyceride is promoted, and absorption of lipid by small intestines is reduced, and therefore, effect of reducing blood fat is achieved from multiple aspects. Besides, all materials in the invention are natural plant materials, have advantages of being wide in material resource, low in cost and free from toxic and side effects on an organism, can effectively lower blood fat level of a patient with hyperlipaemia, and can suppress atherosclerosis.

A piercing device (A), comprising a piercing body (3) allowed to move forward in a first direction from the inner bottom part of a housing (2) to the tip end of a tubular body (8) and an analysis part (4) disposed in the tubular body (8), wherein the analysis part (4) is formed movable in a second direction when receiving a force in a second direction opposite to the first direction, and when skin (S) is raised, the analysis part (4) is moved in the second direction by following the rise of the skin to properly lead blood (b) from the skin (S) to the analysis part (4).

The invention relates to selenium-rich food for promoting plumbum excretion and a preparation method thereof. The selenium-rich food can not only supplement selenium, but also take special physiological needs of a high lead level crowd into account, can be eaten for a long time, and can meet the special physiological needs of the high lead level crowd. The selenium content in each 100g of the selenium-rich food is greater than or equal to 25 micrograms, and the selenium-rich food can not only safely and effectively meet the needs of selenium by the high lead level crowd, but also effectively reduce the blood lead levels of the high lead level crowd, effectively promotes selenium to be discharged from the body, and improves complication caused by lead poisoning.

The invention discloses an inflatable double-opened-blade protection type puncturing device for a thoracoscope. The inflatable double-opened-blade protection type puncturing device comprises a hollow tube pipe; a pair of clamping arms rotating around a fixed shaft and an airbag mechanism for driving the clamping arms to clamp a thoracoscope lens are arranged at the end part of the hollow pipe body; each clamping arm consists of a long movable blade and a short movable blade; air cavity bags are arranged on the inner lateral faces of the long movable blades and the short movable blades and the surface of the end part of the hollow pipe body; and when the air cavity bags are full of gas, the long movable blades and the short movable blades rotate around the fixing shaft to an expansion state until the long movable blades and the short movable blades are compactly connected with the thoracoscope lens at the bottom of the hollow pipe body. The double-opened movable blades lead bloods at a cut position well, so that the pollution on the thoracoscope lens can be reduced. The airbags at the end parts of the hollow pipe body are prevented from being damaged on intercostals nervus vascularis and the like through the design; and meanwhile, the inflatable double-opened-blade protection type puncturing device has certain effects of hemostasis by compression on the cut. Furthermore, the airbags at the inner sides of the double-opened movable blades form a protection cushion to buffer the upper turning shape of the thoracoscope lens. Therefore, the inner side of the chest wall can be prevented from being damaged.

The invention provides a composition for preventing and treating lead poisoning and a preparation method thereof. The composition for preventing and treating lead poisoning includes component names and mass percentages: 5-50% of Radix Hegaly, 3-30% of Angelica , Salvia 3-40%, Lycium barbarum 3-40%, Poria cocos 5-50%, Forsythia 3-30%, Curcuma 3-30%; The present invention also provides a preparation method of a composition for preventing and treating lead poisoning, It can effectively reduce the femoral lead, blood lead and liver lead levels of lead poisoning patients, and can effectively improve the learning and memory ability of lead poisoning patients. The invention uses Chinese medicinal materials as raw materials, is non-toxic and has no side effects, and can be taken for a long time. Clinical trials have shown that this The invention can effectively reduce the blood lead level of lead poisoning human body and improve the learning and memory ability of lead poisoning children.

The invention discloses a traditional Chinese medicinal composition and an application thereof in the preparation of blood lead reducing medicines. The traditional Chinese medicinal composition is prepared from, by mass, 130-260 parts of Seleno-k-carrageenan, 330-460 parts of Radix Polygonum Multiflorum Preparata, 670-930 parts of calcined oyster shell, 130-240 parts of white peony root from Hangzhou, 100-160 parts of processed Radix Polygalae, 100-240 parts of Acorus gramineus, 100-160 parts of Chinese magnoliavine, and 100-160 parts of raw licorice root. The traditional Chinese medicinal composition reduces the blood lead and brain lead level of lead poisoning rats and newborn mice, reduces the electric shock frequency, improves the memory keeping rate, mitigates lead nerve poisons, improves the NOS activity of hippocampus, effectively reduces the blood lead level of poisoned children, improves the attention deficit hyperactivity disorder of the children, and has no obvious toxic or side effects, so the composition has good promotion and application prospect.

The invention discloses a processing method and an equipment of blood which is discarded. Because of the specificity of the blood processing of a blood station, an ordinary disinfection cabinet cannot meet the disinfection requirement of the blood station, all along the blood station adopts the traditional disinfection way to disinfect, thus the dangers that the disinfection is incomplete, the environment is polluted, and the related personnel who contact with the blood is infected exist. The invention leads blood bags which are required to be processed and provided with pathogenic microorganisms to be arranged in the cabinet which is equipped with a quartz heating tube, an ultraviolet ray disinfection lamp and an ozone generator, under the conditions that the ozone concentration is more than 40 mg / l, and the 253.7 nm ultraviolet intensity radiated by the ultraviolet ray disinfection lamp is more than 140 microwatt / cm<2>, the blood bags are sterilized for 60 to 100 minutes under the temperature of 75 to 90 DEG C. The method not only can thoroughly kill the pathogenic microorganisms outside and inside the blood bags and lead the blood in the blood bags to be congealed into block shape, but also can ensure that the blood bags are not broken in the sterilization process, guarantee the healthy safety of the related personnel, and sever the propagation spread possibility of the contagious diseases through the blood which is discarded.

The invention relates to the field of medicines and nutritional foods, and especially relates to a nutritional food for promoting lead excretion. The nutritional food for promoting lead extraction is produced from polydextrose, resistant dextrin, snow pear powder, monocrystal rock sugar, galactooligosaccharide, whey proteins, oat fibers, apple fibers, calcium L-lactate, konjac flour, Centella asiatica extract, L-ascorbic acid, sodium citrate, sodium caseinate, EDTA ferric sodium salt and zinc gluconate, and preferably is a granule and a chewable tablet. The nutritional food for promoting lead excretion has the advantages of simple formula, comprehensive effects, safety in eating, and good taste, and is suitable for children to eat. A test result shows that the nutritional food has a very ideal lead excretion effect, and can be scientifically taken to significantly reduce the blood lead level of children.

The invention provides a blood lipid level related single nucleotide polymorphism rs4377290 detecting system and related application, particularly determines relevance between single nucleotide polymorphism rs4377290 and blood lipid level, provides application of reagent materials and / or instruments for detecting polymorphism of a rs4377290 locus in a sample of a to-be-tested individual to preparation of a detecting system for assessment of blood lipid level and / or dyslipidemia risks, and further provides the detecting system for assessment of the blood lipid level and / or the dyslipidemia risks. The detecting system comprises the reagent materials and / or instruments for detecting polymorphism of the rs4377290 locus in the sample of the to-be-tested individual, wherein rs4377290 is remarkably related to TC level, and rs4377290 locus T allele carriers are higher in total cholesterol level and / or dyslipidemia risks than non-carriers.

Disclosed here is a novel use of a pharmaceutical composition comprising glutathione or its pharmaceutically acceptable salts or derivatives as active ingredient, in the forms of tablets, capsules, powder, spray and / or liquid, through oral administration, intervene injection, inhale and / or skin transmission, to treat and prevent gout and lead nephropathy. Embodiments of gout and lead nephropathy treatable by the pharmaceutical composition described herein include, without limitation, gout, kidney stones, tophi, hyperuricemia, blood lead, renal disease (lead nephropathy), complications thereof,as well as other conditions caused by lifestyle, genetics, medical conditions, and blood lead level. Symptoms treatable may include inflammatory arthritis, which typically involves a red, tender, hot, and swollen joint.